Articles with "tetravalent" as a keyword



Photo from wikipedia

Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.

Sign Up to like & get
recommendations!
Published in 2017 at "Vaccine"

DOI: 10.1016/j.vaccine.2017.09.063

Abstract: Dengue viruses (DENVs) are re-emerging pathogens transmitted by mosquitoes mainly in tropical and subtropical regions. Each year, they are estimated to infect 390 million people globally. The major challenge confronting dengue vaccine development is the… read more here.

Keywords: tetravalent; consensus; subunit vaccine; vaccine ... See more keywords
Photo from wikipedia

The Symmetric Tetravalent Sulfhydryl-Specific Linker NATBA Facilitates a Combinatorial “Tool Kit” Strategy for Phage Display-Based Selection of Functionalized Bicyclic Peptides

Sign Up to like & get
recommendations!
Published in 2018 at "ACS Omega"

DOI: 10.1021/acsomega.8b01814

Abstract: The rigid conformation of constrained bicyclic peptides provides a number of advantages over larger protein-based ligands, including better chemical stability, enhanced tissue penetration, and a wider field of possible applications. Selective chemical modification strategies are… read more here.

Keywords: tetravalent; phage; linker; bicyclic peptides ... See more keywords
Photo from wikipedia

The dengue virus 4 component of NIAID’s tetravalent TV003 vaccine drives its innate immune signature

Sign Up to like & get
recommendations!
Published in 2022 at "Experimental Biology and Medicine"

DOI: 10.1177/15353702231151241

Abstract: Annually, roughly 2.5 billion people are at risk for dengue virus (DENV) infection, and the incidence of infection has increased 30-fold since its discovery in the 1900s. At present, there are no globally licensed antiviral… read more here.

Keywords: component; tetravalent; innate immune; vaccine ... See more keywords
Photo from wikipedia

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype

Sign Up to like & get
recommendations!
Published in 2018 at "PLoS Neglected Tropical Diseases"

DOI: 10.1371/journal.pntd.0006793

Abstract: Dengue virus (DENV) is the causative agent of dengue fever and dengue hemorrhagic shock syndrome. Dengue vaccine development is challenging because of the need to induce protection against four antigenically distinct DENV serotypes. Recent studies… read more here.

Keywords: protein; tetravalent; vaccine; denv ... See more keywords